2 news items
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
BCDA
14 May 24
on March 4, 2024. Over a mean 20 months of follow-up, patients with advanced chronic heart failure who received a single endomyocardial dose
BioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
BCDA
1 May 24
label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial. Study clinical cardiology leadership
- Prev
- 1
- Next